Profile
Petra Kaufmann is currently Chief Medical Officer at Ovid Therapeutics, Inc. since 2025.
Former positions include Chief Medical Officer at Affinia Therapeutics, Inc. from 2021 to 2024, SVP, Head-Clinical Development & Analytics at Novartis Gene Therapies, Inc. from 2020 to 2021, Director-Rare Diseases Research at National Institutes of Health from 2015 to 2018, and Chief Medical Officer at Vigil Neuroscience, Inc. Education includes a graduate degree from The Trustees of Columbia University in The City of New York and a doctorate from the University of Bonn.
Petra Kaufmann active positions
| Companies | Position | Start |
|---|---|---|
| OVID THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2025-12-01 |
Former positions of Petra Kaufmann
| Companies | Position | End |
|---|---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Chief Tech/Sci/R&D Officer | 2024-02-29 |
| AVEXIS INC | Corporate Officer/Principal | 2021-01-31 |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | 2018-01-31 |
| VIGIL NEUROSCIENCE, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Petra Kaufmann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
University of Bonn
University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Petra Kaufmann
















